Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry.
Gustavo G M BalbiYasaman AhmadzadehMaria G TektonidouVittorio PengoSavino SciasciaAmaia UgarteH Michael BelmontChary Lopez-PedreraPaul R FortinDenis WahlMaria GerosaGuilherme R de JesúsLanlan JiTatsuya AtsumiMaria EfthymiouD Ware BranchCecilia NalliEsther Rodriguez AlmarazMichelle PetriRicard CerveraJason S KnightBahar Artim-EsenRohan WillisMaria Laura BertolacciniHannah CohenRobert RoubeyDoruk ErkanDanieli Castro de Oliveira Andradenull nullPublished in: Rheumatology (Oxford, England) (2023)
DIAPS indicates substantial damage in aPL-positive patients in APS ACTION cohort. Selected traditional cardiovascular risk factors, steroids use and specific aPL profiles may help to identify patients more prone to present with a higher damage burden.